Factores pronósticos de complicaciones cardiovasculares en pacientes con insuficiencia renal crónica en hemodiálisis
DOI:
https://doi.org/10.23857/dc.v10i1.3726Palabras clave:
Hemodiálisis, enfermedad renal crónica, morbimortalidad, hipertrofia ventricular izquierdaResumen
La aparición de eventos cardiovasculares es 10 a 30 veces mayor en los pacientes sometidos a hemodiálisis que en la población general y constituyen la principal causa de mortalidad. La enfermedad renal crónica está íntimamente relacionada con la enfermedad cardiovascular. Los pacientes con deterioro progresivo de la función renal tienen asociados factores de riesgo cardiovascular tradicionales, que explican en cierta medida el aumento de la morbimortalidad observada. Sin embargo, otros factores de riesgo no tradicionales, y especialmente el desarrollo de hipertrofia ventricular izquierda, contribuyen a magnificar este adverso pronóstico. Es necesario un gran esfuerzo en investigación para poder prevenir muertes prematuras como resultado de estos dos trastornos.
Citas
K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2022 Feb;39(2 Suppl 1):S1-266.
Hallan SI, Dahl K, Oien CM, Grootendorst DC, Aasberg A, Holmen J, et al. Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey. BMJ. 2016;333:1047-50.
Vlagopoulos PT, Sarnak MJ. Traditional and non-traditional cardiovascular risk factors in chronic kidney disease. Med Clin North Am. 2015;89:587-611.
Stevinkel P, Pecoits-Filho R, Lindholm B. Coronary artery disease in end-stage renal disease: No longer a simple plumbing problem. J Am Soc Nephrol. 2013;14:1927-39.
Atiés Sánchez Mirna C, Collado Nieto S. Factores de riesgo y complicaciones cardiovasculares en pacientes con enfermedad renal crónica en hemodiálisis: prevalencia, morbilidad y mortalidad. Rev Cubana Invest Biomed [Internet]. 2012 [citado 7 Jul 2013];31(2):[aprox.
Berl T, Heinrich W. Kidney-heart interactions: epidemiology, pathogenesis and treatment. Clin J Am Soc Nephrol. 2016 Jan;1(1):8-18.
Fariña Peláez RA. Mortalidad en hemodiálisis, factores asociados [tesis]. Santa Clara: HAMC; 2019.
Hillege HL, van Gilst WH, van Veldhuisen DJ, Navis G, Grobbee DE, de Graeff PA, et al. CATS Randomized Trial. Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: the CATS randomized trial. Eur Heart J. 2013 Mar;24(5):412-20.
Factores de riesgo y complicaciones cardiovasculares en los pacientes en diálisis peritoneal. Rev Cub Med Int Emerg [Internet]. 2014 [citado 7 Jul 2013];3(4):[aprox. 7
Valdés S, Rojo Martínez G, Soriguer F. Evolución de la prevalencia de la diabetes tipo 2 en población adulta española. Med Clin Barc. 2017;129(18):716-7.
Informe de diálisis y Trasplante 2020. Sevilla: XL Congreso Nacional de la SEN; 14-17 Oct 2011.
Orth SR. Smoking and the kidney. J Am Soc Nephrol. 2022;132:1663-72.
Prevalencia de enfermedad cardiovascular en la uremia y relevancia de los factores de riesgo cardiovascular. Nefrología [Internet]. 2020
Chanda J, Fenves AZF. Hypertension in patients with chronic kidney disease. Curr Hypertens Rep. 2099; 11:329-36.
-Sarriá Cepeda C. Daptomycin in the treatment of Gram-positive infections in patients with chronic renal failure. Enferm Infecc Microbiol Clin. 2012;30 Suppl 1:38-42. Spanish.
-Verde E, Pérez de Prado A, López-Gómez JM, Quiroga B, Goicoechea M,García-Prieto A, Torres E, Reque J, Luño J. Asymptomatic Intradialytic Supraventricular Arrhythmias and Adverse Outcomes in Patients on Hemodialysis. Clin J Am Soc Nephrol. 2016 Dec 7;11(12):2210-2217.
-Winkelmayer WC, Patrick AR, Liu J, Brookhart MA, Setoguchi S. The increasing prevalence of atrial fibrillation among hemodialysis patients. J Am Soc Nephrol. 2021 Feb;22(2):349-57.
-Goldstein BA, Arce CM, Hlatky MA, Turakhia M, Setoguchi S, Winkelmayer WC. Trends in the incidence of atrial fibrillation in older patients initiating dialysis in the United States. Circulation. 2022 Nov 6;126(19):2293-301.
-Zimmerman D, Sood MM, Rigatto C, Holden RM, Hiremath S, Clase CM. Systematic review and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysis. Nephrol Dial Transplant. 2022 Oct;27(10):3816-22.
-Buiten MS, de Bie MK, Rotmans JI, Gabreëls BA, van Dorp W, Wolterbeek R, Trines SA, Schalij MJ, Jukema JW, Rabelink TJ, van Erven L. The dialysis procedure as a trigger for atrial fibrillation: new insights in the development of atrial fibrillation in dialysis patients. Heart. 2019 May;100(9):685-90.
-Harel Z, Chertow GM, Shah PS, Harel S, Dorian P, Yan AT, Saposnik G, Sood MM, Molnar AO, Perl J, Wald RM, Silver S, Wald R. Warfarin and the Risk of Stroke and Bleeding in Patients With Atrial Fibrillation Receiving Dialysis: A Systematic Review and Meta-analysis. Can J Cardiol. 2017 Jun;33(6):737-746.
-Reque J, Quiroga B, Ruiz C, Villaverde MT, Vega A, Abad S, Panizo N, López-Gómez JM. [Pulmonary hypertension in hemodialysis patients: Prevalence and associated factors]. Med Clin (Barc). 2016 Feb 19;146(4):143-7.
-Reque J, Quiroga B, Ruiz C, Villaverde MT, Vega A, Abad S, Panizo N, López-Gómez JM. Pulmonary hypertension is an independent predictor of cardiovascular events and mortality in haemodialysis patients. Nephrology (Carlton). 2016 Apr;21(4):321-6.
-Sise ME, Courtwright AM, Channick RN. Pulmonary hypertension in patients with chronic and end-stage kidney disease. Kidney Int. 2018 Oct;84(4):682-92.
-Reque J, Garcia-Prieto A, Linares T, Vega A, Abad S, Panizo N, Quiroga B, Collado Boira EJ, López-Gómez JM. Pulmonary Hypertension Is Associated with Mortality and Cardiovascular Events in Chronic Kidney Disease Patients. Am J Nephrol. 2017;45(2):107-114.
-Bolignano D, Lennartz S, Leonardis D, D''Arrigo G, Tripepi R, Emrich IE, Mallamaci F, Fliser D, Heine G, Zoccali C. High estimated pulmonary artery systolic pressure predicts adverse cardiovascular outcomes in stage 2-4 chronic kidney disease. Kidney Int. 2018 Jul;88(1):130-6.
-Greiner S, Jud A, Aurich M, Hess A, Hilbel T, Hardt S, Katus HA, Mereles D. Reliability of noninvasive assessment of systolic pulmonary artery pressure by Doppler echocardiography compared to right heart catheterization: analysis in a large patient population. J Am Heart Assoc. 2019 Aug 21;3(4).
Martinez-Vea A, Bardají A, García C, Ridao C, Richart C, Oliver JA.. Long-term myocardial effects of correction of anemia with recombinant human erythropoietin in aged patients on hemo-dialysis.. Am J Kidney Dis, 19 (2013), pp. 353-7
-Manjunath G, Tighiouart H, Coresh J, Macleod B, Salem DN, Griffith JL, et al.. Level of kidney function as a risk factor for cardiovascular outcomes in the elderly..Kidney Int, 63 (2033), pp. 1121-9
-Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, et al.. Chronic kidney disease and mortality risk: a systematic review.. J Am Soc Nephrol, 17 (2016), pp. 2034-
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2024 Alicia Valentina Pillasagua López, Luisa Lisbeth Meza Valdez, Jairo José Ponce López, Shirley Tatiana Calderón Anchundia
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
Authors retain copyright and guarantee the Journal the right to be the first publication of the work. These are covered by a Creative Commons (CC BY-NC-ND 4.0) license that allows others to share the work with an acknowledgment of the work authorship and the initial publication in this journal.
